Clariscan

Clariscan (Gadoteric Acid) is a contrast agent used in MRI scans to enhance image clarity. It is administered intravenously and is manufactured by GE Healthcare AS in the EU.

Clariscan is primarily used to improve the visibility of internal body structures during magnetic resonance imaging (MRI). This contrast agent helps in diagnosing various conditions by making abnormalities more apparent. It is often used in MRI scans of the brain, spine, and other body parts to provide clearer images for better diagnostic accuracy.

Clariscan works by temporarily altering the magnetic properties of tissues, which enhances the contrast in MRI images. This can help healthcare professionals identify and evaluate abnormalities more effectively. The effects are typically short-lived and are designed to provide clear imaging during the scan.

Clariscan should be used with caution in individuals with a history of allergic reactions to contrast agents. It is important to inform your healthcare provider about any existing medical conditions or allergies before administration. Proper monitoring during and after the procedure is recommended.

Clariscan may interact with certain medications or medical conditions. It is important to discuss all current medications and health conditions with your healthcare provider before using this contrast agent. Specific interactions with other drugs are not commonly reported, but individual responses can vary.